Alprazolam

阿普唑仑

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameAlprazolam
Drug Alias NameAlprazolamum阿普唑他阿普唑伦贊安諾錠Niravam +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsPanic DisorderAnxiety DisordersAnxiety +[6] 
Global Approved IndicationsPanic DisorderAnxiety Disorders
Approved Indications in ChinaPanic DisorderAnxiety Disorders
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoFinland +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUpjohn Us 2 LlcEngage Therapeutics IncTakeda Pharmaceutical Co Ltd +[4] 
Inactive CompaniesViatrisSandozNova Pneuma Inc +[14] 
Active IndicationsPanic DisorderAnxiety Disorders
Inactive IndicationsAnxietySubstance-Related DisordersDiabetes Mellitus, Type 1 +[4] 

Other Information

ATC CodeN05BA12
Related LinksWikipediaDrugBankKEGG